The lung cancer patient quality of life during the first line of treatment – multicenter prospective data
SouhrnVchodiska: Navzdory rozvoji protindorov lby karcinomu v poslednch dekdch je kvalita ivota (quality of life -QoL) tchto pacient patn.Clem tto prce bylo zmapovat QoL nemocnch s ndory plic v prbhu 1. linie modern protindorov terapie v R.Materil a metody: Jedn se o prospektivn multicentrickou prci realizovanou na tech pneumoonkologickch pracovitch ve Fakultnch nemocnicch Brno, Olomouc a Plze.V obdob
Authors
- Lenka Jakubíková
- Martin Svatoň (ORCID: https://orcid.org/0000-0002-6821-8677)
- Monika Bratová (ORCID: https://orcid.org/0000-0001-9994-480X)
- Juraj Kultan
- Michal Svoboda (ORCID: https://orcid.org/0000-0003-0312-2524)
- Kristián Brat (ORCID: https://orcid.org/0000-0003-1674-228X)
Publication Details
- Journal
- Klinicka onkologie
- Published
- 2025-04-15
- DOI
- https://doi.org/10.48095/ccko202597
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00